Indaptus Therapeutics (INDP) Common Equity (2020 - 2026)
Indaptus Therapeutics' Common Equity came in at $11.37 million for Q2 2026, compared with -$1.67 million a year earlier and up 811.4% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Indaptus Therapeutics' Common Equity was $3.15 million, down 20.1% from FY2024.
- Common Equity has declined in each of the last four years.
- Going back by year, Common Equity was $3.94 million in FY2024 (-67.3%), $12.08 million in FY2023 (-51.0%), $24.63 million in FY2022 (-31.4%) and $35.9 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Common Equity since Q4 2023.
- The year-over-year decline in Common Equity has ranged between 20.1% (Q4 2025) and 70.1% (Q1 2025) over the last five years.
- Business Quant data shows INDP's Common Equity at $1.25 million (Q1 2026), $3.15 million (Q4 2025) and $4.61 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Indaptus Therapeutics | 185.93 Mn | 158.54 Mn | - | 11.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.37 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 3.15 Mn |
| Sep 30, 2025 | 4.61 Mn |
| Jun 30, 2025 | -1.67 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 9.36 Mn |
| Dec 31, 2023 | 12.08 Mn |
| Sep 30, 2023 | 15.33 Mn |
| Jun 30, 2023 | 18.63 Mn |
| Mar 31, 2023 | 21.19 Mn |
| Dec 31, 2022 | 24.63 Mn |
| Sep 30, 2022 | 27.57 Mn |
| Jun 30, 2022 | 30.41 Mn |
| Mar 31, 2022 | 33.36 Mn |
| Dec 31, 2021 | 35.90 Mn |
| Sep 30, 2021 | 38.08 Mn |
API Access
Indaptus Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();